Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Stock market Upadate Monday 17 April 2023. Stocks in Focus .

 

STOCK MARKET UPDATE 

1. Infosys 

Infosys' fourth-quarter results were disappointing due to a 3% sequential decline in constant currency revenue. The working edges were additionally under tension at 21%. Infosys ADRs fell nearly 9% on Thursday following the results. 

 2. HDFCBANK

The stock is likely to react negatively. For the quarter that ended in March, HDFC Bank's net profit increased by 20% year-over-year (YoY) to Rs 12,047 crore. To Rs 23,352 crore, net interest income increased by 24% year-over-year.


3. Angel One, Just Dial, and TV 18 Broadcast will release their fourth quarter results, so investors' attention will be focused on their shares.


4. GTPL Hathway 

GTPL Hathway reported a Rs 12 crore net loss for the March quarter. In the mean time, income came in at Rs 692 crore.


5. Zydus Lifesciences

 The United States Food and Drug Administration (USFDA) has granted Zydus Lifesciences final authorization to manufacture and market Isoproterenol Hydrochloride injection.


6. ZEE Entertainment

According to reports, Openheimer is likely to sell its 5.65 percent stake in ZEE Entertainment through block deals.


7. On April 13, Muthoot Finance paid off $225 million in external commercial borrowings before they were due.


8. Brightcom The Securities and Exchange Board of India (SEBI) has filed a show cause notice-cum-interim order against Brightcom Group and its directors on the grounds that the company's financial statements contain significant fraud.


9. Goodbye Metaliks

Goodbye Metaliks, which should hold its executive gathering to support monetary outcomes, informed the trades that it will be rescheduled because of undeniable conditions. 



This post first appeared on Invehelp, please read the originial post: here

Share the post

Stock market Upadate Monday 17 April 2023. Stocks in Focus .

×

Subscribe to Invehelp

Get updates delivered right to your inbox!

Thank you for your subscription

×